Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors

PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors
Conditions:   HER2-positive Breast Cancer;   HER2-positive Gastric Cancer;   HER2-positive Bladder Cancer;   HER2-positive Solid Tumor
Intervention:   Drug: PRS-343 in Combination with Atezolizumab
Sponsor:   Pieris Pharmaceuticals, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 16, 2019 / by / in
Comments